As of 2024-12-14, the Fair Value of Elicera Therapeutics AB (ELIC.ST) is -2.96 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.77 SEK, the upside of Elicera Therapeutics AB is -266.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | - | 5Y Avg | |
| Net income | -13.12 | -19.44 | -16.40 | - | -16.32 | |
| YoY growth | -364.75% | -48.16% | 15.64% | - | -132.42% | |
| Market Cap (mil) | 62.29 |
| P/E | |
| Forward P/E |
| EPS | -0.59 |
| Avg earnings growth rate | -132.42% |
| TTM earnings | -20.79 |